Home
News
Create
Screeners
Insights
Dr Lalchandani Labs
16.
71
-16.71
(-100.00%)
Market Cap
₹14.50 Cr
PE Ratio
34.81
Industry
Healthcare Services
Buy
Sell
Company Performance:
1D
-100.00%
1M
-100.00%
6M
-100.00%
1Y
-100.00%
5Y
-100.00%
View Company Insights
Latest news about Dr Lalchandani Labs
Dr Lalchandani Labs Publishes Newspaper Notice for Rights Issue Extension
4 days ago
Dr Lalchandani Labs Limited has published newspaper advertisements in Financial Express and Jansatta on February 17, 2026, formally communicating the extension of its rights issue closing date from February 20 to February 27, 2026. The company also extended the on-market trading deadline for rights entitlements to February 24, 2026, with Managing Director Arjan Lal Chandani signing the regulatory submission to BSE Limited.
Dr Lalchandani Labs Limited Completes Rights Issue Material Dispatch for ₹433.20 Lakhs Offering
Jan 31, 2026
Dr Lalchandani Labs Approves ₹4.33 Crore Rights Issue with 1:1 Entitlement Ratio
Jan 20, 2026
Dr Lalchandani Labs Receives BSE In-Principle Approval for Rights Issue
Dec 15, 2025
Dr Lalchandani Labs Appoints New Independent Director and Expands Authorized Capital
Sep 05, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation